Скачать
Exploring daratumumab as a treatment option for patients with T-ALL
Автор: VJHemOnc – Video Journal of Hematology & HemOnc
Загружено: 21 июл. 2022 г.
Просмотров: 88 просмотров
Описание:
In this video, Robin Foà, MD, Sapienza University of Rome, Rome, Italy, discusses the results of a CAMPUS ALL study that evaluated the use of daratumumab for the treatment of relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL). Prof. Foà first emphasizes the activity of this agent in patients with T-ALL and then goes on to explain the need for more trials in this disease area. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
